Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects

NCT01453296 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GW642444
DRUG: Placebo

Sponsor

GlaxoSmithKline